Manufacturers Life Insurance Company, The Tarsus Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 46,777 shares of TARS stock, worth $2.16 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,777
Previous 32,929
42.05%
Holding current value
$2.16 Million
Previous $1.08 Million
139.15%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TARS
# of Institutions
201Shares Held
40.5MCall Options Held
72.7KPut Options Held
313K-
Black Rock Inc. New York, NY3.27MShares$151 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.24MShares$149 Million2.92% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.53MShares$117 Million5.35% of portfolio
-
Jennison Associates LLC2.5MShares$115 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$104 Million9.38% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.23B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...